Add like
Add dislike
Add to saved papers

Physiological effects of medetomidine-zolazepam-tiletamine immobilization in black bears.

A combination of medetomidine-zolazepam-tiletamine (MZT) was used to immobilize four black bears (Ursus americanus). The drugs were used at a dose of approximately 52 micrograms/kg of medetomidine, 0.86 mg/kg of zolazepam, and 0.86 mg/kg of tiletamine. Induction occurred in 6.3 +/- 3.3 min (mean +/- SD). The combination produced minimal adverse cardiopulmonary effects. Hypertension occurred in all four bears. Oxygenation and ventilation was good in three of the four bears. One bear demonstrated slight hypoxemia and hypoventilation at 15 min following drug administration. At one 1 hr following drug administration atipamezole was administered at a dose of approximately 240 micrograms/kg. Recovery time was taken as the time from administration of the atipamezole until the time that the bear was sitting in the trap. Recovery occurred in 6.0 +/- 4.1 min. MZT produced rapid, reliable immobilization in black bears with minimal adverse physiological effects. Immobilization, produced by this combination, was readily reversible with atipamezole.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app